Acta Oncologica, 1651-226X

Tidskrift

Fler filtreringsmöjligheter
  1. 2003
  2. A systematic overview of radiation therapy effects in uterine cancer (corpus uteri)

    N Einhorn, C Trope, Mona Ridderheim, K Boman, B Sorbe & Eva Cavallin-Ståhl, 2003, I: Acta Oncologica. 42, 5-6, s. 557-561

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Costs of radiotherapy

    Anders Norlund, 2003, I: Acta Oncologica. 42, 5-6, s. 411-415

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Developments in radiotherapy

    H Svensson & Torgil Möller, 2003, I: Acta Oncologica. 42, 5-6, s. 430-442

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Effects of probucol on endothelial damage by 5-fluorouracil.

    Sara Kinhult, Maria Albertsson, Jan Eskilsson & Magdalena Cwikiel, 2003, I: Acta Oncologica. 42, 4, s. 304-308

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment.

    Gunilla Chebil, Pär-Ola Bendahl & Mårten Fernö, 2003, I: Acta Oncologica. 42, 1, s. 43-47

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Follow-up after colorectal cancer surgery

    B Ohlsson & Birger Pålsson, 2003, I: Acta Oncologica. 42, 8, s. 816-826

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  8. Radiation therapy dose delivery

    KA Johansson, Sören Mattsson, A Brahme, J Carlsson, B Zackrisson & Ingemar Turesson, 2003, I: Acta Oncologica. 42, 2, s. 85-91

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Radiotherapy and cancer care in Sweden.

    Torgil Möller, Nina Einhorn, Christer Lindholm, Ulrik Ringborg & Hans Svensson, 2003, I: Acta Oncologica. 42, 5-6, s. 366-375

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Radiotherapy practices in Sweden compared to the scientific evidence

    C Lindholm, Eva Cavallin-Ståhl, J Ceberg, JE Frodin, B Littbrand & TR Moller, 2003, I: Acta Oncologica. 42, 5-6, s. 416-429

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Radiotherapy techniques in current use in Sweden.

    Torgil Möller, Jeanette Ceberg, Nina Einhorn, Christer Lindholm, Urban Nylén & Hans Svensson, 2003, I: Acta Oncologica. 42, 5-6, s. 376-386

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Research and development of radiation therapy in clinical routines

    B Zackrisson, Sören Mattsson, Elisabeth Kjellén & B Glimelius, 2003, I: Acta Oncologica. 42, 2, s. 115-122

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. The cost of treating pancreatic cancer--a cohort study based on patients' records from four hospitals in Sweden.

    Jonas Hjelmgren, Jeanette Ceberg, Ulf Persson & Thor Alvegård, 2003, I: Acta Oncologica. 42, 3, s. 218-226

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. The potential of proton and light ion beams in radiotherapy

    I Turesson, KA Johansson & Sören Mattsson, 2003, I: Acta Oncologica. 42, 2, s. 107-114

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001 - Summary and conclusions

    U Ringborg, D Bergqvist, B Brorsson, Eva Cavallin-Ståhl, J Ceberg, N Einhorn, JE Frodin, J Jarhult, G Lamnevik, C Lindholm, B Littbrand, A Norlund, U Nylen, W Rosen, H Svensson & TR Moller, 2003, I: Acta Oncologica. 42, 5-6, s. 357-365

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. 2002
  17. 131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.

    Ola Lindén, Jan Tennvall, Cecilia Hindorf, Eva Cavallin-Ståhl, Karl-Johan Lindner, Tomas G Ohlsson, Karin Wingårdh & Sven-Erik Strand, 2002, I: Acta Oncologica. 41, 3, s. 297-303

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin (R)) on a named patient basis in Sweden

    J Andersson, B Linderholm, G Greim, B Lindh, H Lindman, Jan Tennvall, L Tennvall-Nittby, D Pettersson-Skold, A Sverrisdottir, M Soderberg, S Klaar & J Bergh, 2002, I: Acta Oncologica. 41, 3, s. 276-281

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Chemoradiotherapy of esophageal cancer.

    Maria Albertsson, 2002, I: Acta Oncologica. 41, 2, s. 118-123

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  20. Cyclin D3 protein content in human renal cell carcinoma in relation to cyclin D1 and clinico-pathological parameters

    Y Hedberg, G Roos, B Ljungberg & Göran Landberg, 2002, I: Acta Oncologica. 41, 2, s. 175-181

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Erythropoietin treatment in metastatic breast cancer--effects on Hb, quality of life and need for transfusion.

    Anna-Maria Olsson, Jan-Henry Svensson, Judit Sundström, Stefan Bergström, Thomas Edekling, Göran Carlsson, Jörgen Hansen, Birgitta Svensson & Maria Albertsson, 2002, I: Acta Oncologica. 41, 6, s. 517-524

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Interactions between chemotherapy, endocrine therapy and radiation

    B Glimelius, B Nordenskjold, Elisabeth Kjellén & B Zackrisson, 2002, I: Acta Oncologica. 41, 7-8, s. 635-638

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Medical imaging for improved tumour characterization, delineation and treatment verification

    E Forsell-Aronsson, Elisabeth Kjellén, Sören Mattsson & M Hellstrom, 2002, I: Acta Oncologica. 41, 7-8, s. 604-614

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy

    G Enblad, Anita Gustavsson, C Sundstrom & B Glimelius, 2002, I: Acta Oncologica. 41, 7-8, s. 659-667

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Physical performance, toxicity, and quality of life as assessed by the physician and the patient

    ML Luoma, L Hakamies-Blomqvist, J Sjostrom, H Mouridsen, A Pluzanska, Per Malmström, NO Bengtsson, R Hultborn, B Ostenstaad, I Mjaaland, V Valvere, E Wist, G Baldursson, J Ahlgren & C Blomqvist, 2002, I: Acta Oncologica. 41, 1, s. 44-49

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Randomized trial of single agent paclitaxel given weekly versus every three weeks and with peroral versus intravenous steroid premedication to patients with ovarian cancer previously treated with platinum

    P Rosenberg, H Andersson, K Boman, Mona Ridderheim, B Sorbe, U Puistola & G Paro, 2002, I: Acta Oncologica. 41, 5, s. 418-424

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Sensitizing and protective substances in radiation therapy and predictive assays

    B Zackrisson, Elisabeth Kjellén, B Glimelius, J Carlsson, B Littbrand & Ingemar Turesson, 2002, I: Acta Oncologica. 41, 7-8, s. 615-622

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Swedish Cancer Society radiation therapy research investigation.

    Sören Mattsson, Anders Brahme, Jörgen Carlsson, Juliana Denekamp, Eva Forssell-Aronsson, Mikael Hellström, Karl-Axel Johansson, Elisabeth Kjellén, Bo Littbrand, Bo Nordenskjöld, Bo Stenerlöw, Ingela Turesson, Björn Zackrisson & Bengt Glimelius, 2002, I: Acta Oncologica. 41, 7-8, s. 596-603

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Therapy with radiopharmaceuticals

    J Carlsson, E Forssell-Aronsson, B Gliemlius & Sören Mattsson, 2002, I: Acta Oncologica. 41, 7-8, s. 623-628

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. 2001
  31. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus

    Dag Stockeld, Jan Tennvall, Gunnar Wagenius, Maria Albertsson, Lars Backman, Ola Brodin, Magdalena Cwikiel, Lars Granstrom, Gunnar Gustafsson, Sven Gustavsson, Göran Hambraeus, Rolf Lewensohn, Svante Sjöstedt, Hans Strander, Bengt Aberg & Jan Fagerberg, 2001, I: Acta Oncologica. 40, 5, s. 566-573

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. A systematic overview of chemotherapy effects in ovarian cancer

    T Högberg, B Glimelius, P Nygren & SBU-group. Swedish Council of Technology Assessment in Health Care SBU-group. Swedish Council of Technology Assessment in Health Care, 2001, I: Acta oncologica (Stockholm, Sweden). 40, 2-3, s. 340-60

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  33. Cyclin D1 overexpression versus response to induction chemotherapy in squamous cell carcinoma of the head and neck--preliminary report

    Jan Åkervall, Eva Brun, Michael Dictor & Johan Wennerberg, 2001, I: Acta Oncologica. 40, 4, s. 505-511

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Gender and time differences in initial location and histological grade of non-Hodgkin's lymphomas in Southern Sweden

    L Brandt, J Brandt, H Olsson, H Anderson & T Möller, 2001, I: Acta Oncologica. 40, 4, s. 479-84 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Histopathological and cell biological factors of ductal carcinoma in situ before and after the introduction of mammographic screening

    Ingrid Idvall, Christina Andersson, Ghita Fallenius, Christian Ingvar, Anita Ringberg, Carina Forsare, Måns Åkerman & Mårten Fernö, 2001, I: Acta Oncologica. 40, 5, s. 653-659

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Polarographic pO(2) measurements of intra-abdominal adenocarcinoma in connection with intraoperative radiotherapy before and after change of oxygen concentration of anaesthetic gases

    Sten Graffman, Peter Björk, Per Ederoth & Ingemar Ihse, 2001, I: Acta Oncologica. 40, 1, s. 105-107

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Prognostic value of histopathological response to radiotherapy and microvessel density in oral squamous cell carcinomas

    Eva Brun, Ulf Zätterström, Elisabeth Kjellén, Peter Wahlberg, Roger Willen, Arne Brun, Roland Perfekt & Jan Tennvall, 2001, I: Acta Oncologica. 40, 4, s. 491-496

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. The nation-wide Swedish family-cancer database--updated structure and familial rates

    K Hemminki, Xinjun Li, K Plna, C Granström & P Vaittinen, 2001, I: Acta oncologica (Stockholm, Sweden). 40, 6, s. 772-7 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions

    B Glimelius, J Bergh, L Brandt, B Brorsson, B Gunnars, L Hafström, U Haglund, T Högberg, K G Janunger, P E Jönsson, G Karlsson, E Kimby, G Lamnevik, S Nilsson, J Permert, P Ragnhammar, S Sörenson & P Nygren, 2001, I: Acta oncologica (Stockholm, Sweden). 40, 2-3, s. 135-54

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  40. 2000
  41. Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group

    P Boiesen, Pär-Ola Bendahl, Lola Anagnostaki, H Domanski, E Holm, Ingrid Idvall, S Johansson, O Ljungberg, Anita Ringberg, G Ostberg & Mårten Fernö, 2000, I: Acta Oncologica. 39, 1, s. 41-45

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Liposuction gives complete reduction of chronic large arm lymphedema after breast cancer.

    Håkan Brorson, 2000, I: Acta Oncologica. 39, 3, s. 407-420

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Residual mass in aggressive lymphoma--does size, measured by computed tomography, influence clinical outcome?

    M Rodriguez-Catarino, Mats Jerkeman, H Ahlstrom, B Glimelius & H Hagberg, 2000, I: Acta Oncologica. 39, 4, s. 485-489

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. 1998
  45. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV

    Mef Nilbert, G Saeter, I Elomaa, O R Monge, Thomas Wiebe & T A Alvegard, 1998, I: Acta Oncologica. 37, 4, s. 375-378

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Verification of single beam treatment planning using a ferrous dosimeter gel and MRI (FeMRI)

    S A Bäck, Peter Magnusson, L E Olsson, A Montelius, A Fransson & S Mattsson, 1998, I: Acta Oncologica. 37, 6, s. 561-6 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. 1997
  48. Dosimeter gel and MR imaging for verification of calculated dose distributions in clinical radiation therapy

    S A Johansson, P Magnusson, A Fransson, L E Olsson, J O Christoffersson, A Montelius & S Mattsson, 1997, I: Acta Oncologica. 36, 3, s. 283-90 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Early prediction of treatment outcome in head and neck cancer with 2-18FDG PET

    Eva Brun, Tomas G Ohlsson, Kjell Erlandsson, Elisabeth Kjellén, Anders Sandell, Jan Tennvall, Johan Wennerberg & Sven-Erik Strand, 1997, I: Acta Oncologica. 36, 7, s. 741-747

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Intra- and inter-laboratory reproducibility of estrogen and progesterone receptor enzyme immunoassay in breast cancer cytosol samples--a Swedish multicenter study. Swedish Society of Cancer Study Group

    Mårten Fernö, Pär-Ola Bendahl, Ann Brisfors, Karin Byman, Maud Ekeberg, Lilianne Ferraud, Kjell Grankvist, Bertil Hjalmers, Anita Nilsson, Gunilla Sellberg, Lambert Skoog, Olle Stal & Ingalill Wingmo, 1997, I: Acta Oncologica. 36, 8, s. 793-798

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. 1996
  52. A Monte-Carlo program converting activity distributions to absorbed dose distributions in a radionuclide treatment planning system

    Magnus Tagesson, Michael Ljungberg & Sven-Erik Strand, 1996, I: Acta Oncologica. 35, 3, s. 367-372

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Cell survival after Auger electron emission from stable intracellular indium exposed to monochromatic synchrotron radiation

    Ann-Charlotte Jonsson, Bo-Anders Jönsson, Sven-Erik Strand, Gustav Grafström & Per Spanne, 1996, I: Acta Oncologica. 35, 7, s. 947-952

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer--ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group

    C Tropé, H Andersson, E Björkholm, B Frankendal, A Himmelman, T Högberg, G Horvath, B Petterson, H Persson, M Ryberg, E Simonsen, B Sorbe, U Stendahl & B Westholm, 1996, I: Acta oncologica (Stockholm, Sweden). 35 Suppl 8, s. 109-18 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Extracorporeal immunoadsorption from whole blood based on the avidin-biotin concept. Evaluation of a new method

    Michael Garkavij, Jan Tennvall, Sven-Erik Strand, Rune Nilsson, Lars Lindgren, Jangin Chen, Martin Isaksson, Håkan Eriksson & Hans-Olof Sjögren, 1996, I: Acta Oncologica. 35, 3, s. 309-312

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. Genetic predisposition to breast cancer

    Håkan Olsson & Åke Borg, 1996, I: Acta oncologica (Stockholm, Sweden). 35, 1, s. 1-8 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift